• Patient site
  • VERACYTE SITE
  • VERACYTE Portal
  • LATEST NEWS & EVIDENCE
  • Patient/Physician Stories
  • Events
  • Practice Resources
  • Patient site
  • VERACYTE SITE
  • VERACYTE Portal
  • LATEST NEWS & EVIDENCE
  • Patient/Physician Stories
  • Events
  • Practice Resources
Which tests interest you (select all that apply) *
More about you *
How can we help?
Veracyte representatives are happy to assist you and discuss how to integrate our tests into your practice. Monday-Friday, 5:30AM - 5PM (Pacific Time)

Headquarters

6000 Shoreline Court, Suite 300

South San Francisco, CA 94080

Client services

+1.844.464.5864 Office

+1.650.243.6335 Fax

Support email

support@veracyte.com

References: 1. Data on file. 2. Hu M, et al, JCEM, 2021. 3. Patel KN, et al, JAMA Surg, 2018. 4. Ali SZ, et al, Cancer Cytopathol, 2019. 5. Hao Y, et al, BMC Syst Biol, 2019. 6. Angell TE, et al, Thyroid, 2019. 7. San Martin VT, et al, JCEM 2019. 8. Andrioli M, et al, Endocr Pathol, 2020. 9. Wei S, et al, Cancer Cytopathol, 2019. 10. Harrell RM, et al, Endocr Pract, 2018. 11. Endo M, et al, Thyroid, 2019. 12. Goldner W, et al, Thyroid, 2019. 13. Stack, et al, ATA, 2019

 

Afirma is available as part of Veracyte’s CLIA-validated laboratory developed test (LDT) service. This test has not been cleared or approved by the FDA.

Contact us today

Call 1.888.923.4762 or email support@veracyte.com

TERMS & CONDITIONS
PRIVACY POLICY

© 2022 Veracyte, Inc. All rights reserved.

Afirma, Veracyte, the Afirma logo, and the Veracyte logo are registered trademarks of Veracyte.